ResearcherMashhad University of Medical SciencesNo recent work listed

Newsha Sardarzade

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5116639488. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

Association of a Genetic Variant in the Cyclin-Dependent Kinase Inhibitor 2B with Risk of Pancreatic Cancer. Co-author DOI 10.52547/rbmb.11.2.336 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Amir Avan · 1 shared paper, 2022 · strength 0.13
- Paper Association of a Genetic Variant in the Cyclin-Dependent Kinase Inhibitor 2B with Risk of Pancreatic Cancer. DOI 10.52547/rbmb.11.2.336 ↗
Gordon A. Ferns · 1 shared paper, 2022 · strength 0.13
- Paper Association of a Genetic Variant in the Cyclin-Dependent Kinase Inhibitor 2B with Risk of Pancreatic Cancer. DOI 10.52547/rbmb.11.2.336 ↗
Mohsen Aliakbarian · 1 shared paper, 2022 · strength 0.13
- Paper Association of a Genetic Variant in the Cyclin-Dependent Kinase Inhibitor 2B with Risk of Pancreatic Cancer. DOI 10.52547/rbmb.11.2.336 ↗
Fatemeh Khojasteh‐Leylakoohi · 1 shared paper, 2022 · strength 0.13
- Paper Association of a Genetic Variant in the Cyclin-Dependent Kinase Inhibitor 2B with Risk of Pancreatic Cancer. DOI 10.52547/rbmb.11.2.336 ↗
Majid Khazaei · 1 shared paper, 2022 · strength 0.13
- Paper Association of a Genetic Variant in the Cyclin-Dependent Kinase Inhibitor 2B with Risk of Pancreatic Cancer. DOI 10.52547/rbmb.11.2.336 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.